Stock listing
RV7 Stock Price, News, Filings & Events — Halozyme Therapeutics, Inc.
Selected listing: RV7 · BX · CHF · CH
This page tracks Halozyme Therapeutics, Inc.'s RV7:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RV7:BX. RV7:BX is the stock-level entry point for investors researching Halozyme Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- RV7:BX
- Asset type
- Stock
- Market cap
- $11.96B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX
- Currency
- CHF
Halozyme Therapeutics, Inc. RV7:BX stock context
This page tracks Halozyme Therapeutics, Inc.'s RV7:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RV7:BX. RV7:BX is the stock-level entry point for investors researching Halozyme Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Halozyme Therapeutics, Inc.
Halozyme Appoints Dannielle Appelhans to its Board of Directors
August 18, 2026
Halozyme to Report Second Quarter 2026 Financial and Operating Results
July 23, 2026
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA...
July 21, 2026
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA...
July 20, 2026
Halozyme Appoints David Ramsay as President Drug Delivery
June 30, 2026
Halozyme Therapeutics, Inc. earnings calls
Halozyme Therapeutics, Inc. (HALO) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q4 2025 Earnings Call
January 28, 2026 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for RV7:BX.
Halozyme Therapeutics, Inc. company profile
View the public company page for Halozyme Therapeutics, Inc. on 6ix.
Halozyme Therapeutics, Inc. news
Read company news and market updates connected to Halozyme Therapeutics, Inc..
Halozyme Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Halozyme Therapeutics, Inc..
Alternate listings
HALO:NASDAQ
US · USD
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
RV7:GETTEX
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
RV7:TRADEGATE
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
A0DLHS:LSX
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
HALO:BOATS
US · USD
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
RV7:FWB
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
A0DLHS:LS
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
HALO:BMV
MX · MXN
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
0J2O:LSE
GB · USD
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
1HALO:MIL
IT · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
HALO:BIVA
MX · MXN
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.
RV7:DUS
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is RV7:BX.